Biobase Acquires Incyte s Proteome Group to Expand Product Line and US Presence | GenomeWeb

Incyte has jettisoned the last of its database holdings with the sale of its Proteome subsidiary to Biobase of Wolfenb ttel, Germany.

The deal effectively closes the door on Incyte’s information business, but should open another one for Biobase, which gains access to Proteome’s BioKnowledge Library and LifeSeq Foundation databases — along with an important foothold in the US market.

Financial terms for the acquisition were not disclosed, but Biobase said it financed the transaction through a fund managed by Avida, a private equity firm.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.